Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.
about
The roles of viruses in brain tumor initiation and oncomodulationThe hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironmentHypoxia enhances the replication of oncolytic herpes simplex virusAdvances in preclinical investigation of prostate cancer gene therapy.Hypoxia enhances antibody-dependent dengue virus infectionSpores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors in vivoImpact of tumor microenvironment on oncolytic viral therapyOncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesDesign and application of oncolytic HSV vectors for glioblastoma therapy.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyClostridial spores for cancer therapy: targeting solid tumour microenvironmentClostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoActin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.Gene therapy approaches to enhance bioreductive drug treatment.Adenoviral vector-based strategies for cancer therapy.Pharmacologic and chemical adjuvants in tumor virotherapy.Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Update on oncolytic viral therapy - targeting angiogenesisAntiglioma oncolytic virotherapy: unattainable goal or a success story in the making?HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic mammalian orthoreovirus.Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1alpha.Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacyThe effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).Prospects for combined use of oncolytic viruses and CAR T-cells.A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions.Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
P2860
Q24632829-15F7E686-E861-4221-8425-804DE4671CB7Q28728396-1F723AEA-6D0F-4877-8B37-71247FC7DD43Q33660631-A3924765-4143-4267-B716-5CE319747C0FQ33677054-7F9428CD-F03F-445C-AB7D-B27BAF7EDA99Q33679954-274D72E4-49A9-4739-A22D-F30D2CB7D03DQ33688369-45BD43E9-9224-417B-908E-5469F30246EBQ33895533-C2BCEF72-EEB8-4353-991A-A467A382ADE0Q33924550-51FF1FD9-BC3B-483C-B64A-3D2225A0D590Q35559877-E417F9A5-EE02-4863-A082-30ABAB722F0BQ35657822-32C2A31C-59CB-4FA7-89A5-C6C41C886061Q36037633-011D78DB-555E-4604-8B8F-034E918E61A2Q36495546-5D2A59BE-7CCA-448C-9037-41DC23856235Q36611812-16AE0BEC-A481-427C-8380-FBBDF6309F1EQ36951268-C1EAAAE0-E6A3-402D-B17A-9F6B7C9F475AQ37158473-FBA6E90A-D8D4-4A84-A023-CC9BDB98F851Q37280249-00715B79-0A33-439A-AD51-EBBE26D04D60Q37409025-4D83DF25-C095-4340-83C9-5534BD2A6163Q37492540-00BD4B43-5FDE-4DE0-8BE8-ADE74D0F360FQ38033591-859A9E2B-076D-47FF-A687-DCA7D1A6EAF8Q38128561-C2E33876-2EA4-400E-9712-48D621BCED98Q38218674-442C9783-576D-4B05-AE0A-DC4B6528449DQ38458133-87A68B5B-8FBC-45D5-B4C7-D04A8D6AEEA8Q38920008-8A9782B0-F6FD-4ACD-B0FE-01FC79EAF847Q38929123-56231331-1E63-4DBC-8FE8-F814B965F76FQ39778777-A4895B41-69F3-4FA5-9430-0672643142B5Q39826803-F4F30CEE-F475-45AC-A7BB-57EB76A74BD9Q40318210-06D01E4A-7DAE-4024-A25B-64EC63FF260AQ41934085-9C6EABB0-22F6-4453-BB1D-942C5420105DQ42370561-B7025A0F-C470-4D14-8F14-6AB36E6F364CQ45856648-C411F0A3-CB9A-4871-BFD2-92C0715B9DFEQ47103891-A05A5EA1-ABEB-4165-82A7-25470C834E4EQ47549547-9E76461C-6A2E-4C39-A41C-107BD5339CEEQ49307189-F60FCC0B-944F-4538-9CB8-EAC78AD68813Q54217627-270C5C73-27DE-40DD-8E49-F0539D9B0D18Q56986466-1365E37C-E6EF-4A4C-BA61-CBBB6BA25D70
P2860
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@en
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@nl
type
label
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@en
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@nl
prefLabel
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@en
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@nl
P2093
P2860
P356
P1433
P1476
Hypoxia reduces adenoviral rep ...... n of viral protein expression.
@en
P2093
Sauthoff H
P2860
P2888
P304
P356
10.1038/SJ.GT.3302459
P577
2005-06-01T00:00:00Z
P5875
P6179
1048680568